Suppr超能文献

当代简明综述 2021 年版:COVID-19 与其他呼吸道感染。

Contemporary Concise Review 2021: COVID-19 and other respiratory infections.

机构信息

Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.

Stanley Ho Center for Emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.

出版信息

Respirology. 2022 Aug;27(8):661-668. doi: 10.1111/resp.14305. Epub 2022 Jun 7.

Abstract

Bats are likely the primary source of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Minks are highly susceptible to infection by SARS-CoV-2. Transmission from asymptomatic individuals was estimated to account for over 50% of all transmissions of coronavirus disease 2019 (COVID-19) cases. SARS-CoV-2 is evolving towards more efficient aerosol transmission. Remdesivir, baricitinib, tocilizumab and dexamethasone are frequently used for the treatment of patients with respiratory failure due to COVID-19. There is a rising incidence of non-tuberculous Mycobacterium pulmonary disease globally, with a higher prevalence in Asian countries than in the Western world. Protracted bacterial bronchitis is a common cause of chronic productive cough in childhood. Re-emergence of respiratory syncytial virus may occur after the relaxation of infection control measures and the reopening of borders during COVID-19 pandemic.

摘要

蝙蝠可能是严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的主要来源。水貂极易感染 SARS-CoV-2。无症状感染者的传播估计占所有 2019 年冠状病毒病(COVID-19)病例传播的 50%以上。SARS-CoV-2 正朝着更有效的气溶胶传播方向进化。瑞德西韦、巴瑞替尼、托珠单抗和地塞米松常用于治疗因 COVID-19 导致呼吸衰竭的患者。全球非结核分枝杆菌肺病的发病率正在上升,亚洲国家的患病率高于西方国家。迁延性细菌性支气管炎是儿童慢性湿性咳嗽的常见原因。呼吸道合胞病毒在 COVID-19 大流行期间感染控制措施放松和边境重新开放后可能会再次出现。

相似文献

1
Contemporary Concise Review 2021: COVID-19 and other respiratory infections.
Respirology. 2022 Aug;27(8):661-668. doi: 10.1111/resp.14305. Epub 2022 Jun 7.
2
Human and novel coronavirus infections in children: a review.
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
3
[Respiratory virus infections after hematopoietic cell transplantation].
Rinsho Ketsueki. 2021;62(8):1288-1295. doi: 10.11406/rinketsu.62.1288.
4
Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
J Med Internet Res. 2021 Feb 3;23(2):e25799. doi: 10.2196/25799.
5
COVID-19: a conundrum to decipher.
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
6
Aerosol transmission of SARS-CoV-2 by children and adults during the COVID-19 pandemic.
Pediatr Pulmonol. 2021 Jun;56(6):1389-1394. doi: 10.1002/ppul.25330. Epub 2021 Mar 15.
7
Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
Viruses. 2020 Jun 30;12(7):705. doi: 10.3390/v12070705.
8
The Coronavirus Pandemic: What Does the Evidence Show?
J Nepal Health Res Counc. 2020 Apr 19;18(1):1-9. doi: 10.33314/jnhrc.v18i1.2596.
9
Characteristics and management of asymptomatic SARS-CoV-2 infections.
J Basic Clin Physiol Pharmacol. 2021 Sep 13;33(1):1-7. doi: 10.1515/jbcpp-2021-0159.

本文引用的文献

1
Circulation of Non-SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic.
Open Forum Infect Dis. 2021 Dec 8;9(3):ofab618. doi: 10.1093/ofid/ofab618. eCollection 2022 Mar.
4
Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
Front Immunol. 2021 Dec 6;12:763292. doi: 10.3389/fimmu.2021.763292. eCollection 2021.
5
Factors associated with prolonged duration of viral clearance in non-severe SARS-CoV-2 patients in Osaka, Japan.
Environ Health Prev Med. 2021 Dec 6;26(1):115. doi: 10.1186/s12199-021-01035-y.
8
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar.
Nat Med. 2021 Dec;27(12):2136-2143. doi: 10.1038/s41591-021-01583-4. Epub 2021 Nov 2.
9
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Lancet Respir Med. 2021 Dec;9(12):1419-1426. doi: 10.1016/S2213-2600(21)00435-5. Epub 2021 Oct 18.
10
Nontuberculous mycobacterial lung disease caused by complex - disease burden, unmet needs, and advances in treatment developments.
Expert Rev Respir Med. 2021 Nov;15(11):1387-1401. doi: 10.1080/17476348.2021.1987891. Epub 2021 Oct 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验